Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation

NCT01291316 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01291316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation
Lead sponsor
University Hospital, Geneva
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2010
Completion date
November 30, 2011
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain